Invitae: The Beginning Of An Overdue Rally

Genetic testing concern Invitae rose 10% in trading on Thursday on blowout 1st quarter results. Further gains ahead?

A few weeks ago, I was teasing my marketing partner we should put out a free report entitled the ‘Devil’s Portfolio’ on my three favorite diagnostic plays in this market as each stock was selling…


Fresh Conversations